Aveanna Healthcare Holdings (AVAH) financial statements: income statement, balance sheet and cash flow

Aveanna Healthcare Holdings's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Jan 3, 2026 · FY), Aveanna Healthcare Holdings reported revenue of $2.4B (+20.2% year on year) and net income of $225.0M (+2159.1% year on year).

Income statement

Aveanna Healthcare Holdings income statement, fiscal years

Line item	Jan 3, 2026 · FY	Dec 28, 2024 · FY	Dec 30, 2023 · FY	Dec 31, 2022 · FY
Revenue	$2.4B	$2.0B	$1.9B	$1.8B
Cost of revenue, excluding depreciation and amortization	$1.6B	$1.4B	$1.3B	$1.2B
Branch and regional administrative expenses	$374.5M	$352.8M	$361.0M	$357.2M
Corporate expenses	$163.3M	$125.4M	$113.0M	$137.9M
Depreciation and amortization	$10.5M	$10.8M	$13.8M	$21.3M
Acquisition-related costs	$3.8M	$1.5M	$466.0K	$99.0K
Other operating expense	$1.9M	$5.3M	($6.0M)	$3.7M
Operating income	$256.5M	$139.8M	$8.1M	($642.3M)
Interest income	$2.8M	$498.0K	$327.0K	$679.0K
Interest expense	($140.1M)	($156.6M)	($153.2M)	($107.7M)
Loss on debt extinguishment	($5.9M)	—	—	—
Other (expense) income	($6.4M)	$21.4M	$5.9M	$85.5M
Income before income taxes	$106.9M	$5.1M	($139.0M)	($663.8M)
Income tax benefit (expense)	$118.1M	($16.0M)	$4.5M	$1.8M
Net income (loss)	$225.0M	($10.9M)	($134.5M)	($662.0M)
Net income (loss) per share, basic	$1.11	-$0.06	-$0.71	-$3.57
Weighted average shares of common stock outstanding, basic	203.5M	192.9M	190.0M	185.6K
Net income (loss) per share, diluted	$1.05	-$0.06	-$0.71	-$3.57
Weighted average shares of common stock outstanding, diluted	215.0M	192.9M	190.0M	185.6K

Aveanna Healthcare Holdings income statement, quarters

Line item	Jul 4, 2026 · Q2	Apr 4, 2026 · Q1	Sep 27, 2025 · Q3	Jun 28, 2025 · Q2
Revenue	$670.5M	$647.9M	$621.9M	$589.6M
Cost of revenue, excluding depreciation and amortization	$452.0M	$442.5M	$419.1M	$378.8M
Branch and regional administrative expenses	$97.1M	$95.8M	$95.4M	$90.1M
Corporate expenses	$34.1M	$34.2M	$52.0M	$34.5M
Depreciation and amortization	$2.8M	$3.0M	$2.6M	$2.6M
Acquisition-related costs	$4.4M	$3.1M	($1.2M)	$3.4M
Other operating expense	$144.0K	$0	$418.0K	$151.0K
Operating income	$80.0M	$69.3M	$53.6M	$80.0M
Interest income	$1.3M	$1.7M	$826.0K	$129.0K
Interest expense	($27.8M)	($29.2M)	($35.1M)	($36.0M)
Other income (expense)	$3.0M	$3.1M	($3.0K)	($22.0K)
Income before income taxes	$56.5M	$45.0M	$13.4M	$44.1M
Income tax expense	($16.2M)	($3.3M)	$647.0K	($17.1M)
Net income	$40.3M	$41.7M	$14.1M	$27.0M
Net income per share, basic	$0.19	$0.19	$0.07	$0.13
Weighted average shares of common stock outstanding, basic	217.8M	214.6M	208.9M	201.0M
Net income per share, diluted	$0.18	$0.19	$0.06	$0.13
Weighted average shares of common stock outstanding, diluted	224.9M	222.1M	222.2M	210.4M

Balance sheet

Aveanna Healthcare Holdings balance sheet, fiscal years

Line item	Jan 3, 2026 · FY	Dec 28, 2024 · FY	Dec 30, 2023 · FY	Dec 31, 2022 · FY
Cash and cash equivalents	$193.3M	$84.3M	$43.9M	$19.2M
Patient accounts receivable	$313.4M	$265.2M	$236.6M	$221.2M
Receivables under insured programs	$2.8M	$12.5M	$9.3M	$4.4M
Prepaid expenses	$20.9M	$17.5M	$15.7M	$15.1M
Other current assets	$29.9M	$13.2M	$9.5M	$9.8M
Total current assets	$560.2M	$392.7M	$314.9M	$269.8M
Property and equipment, net	$16.7M	$17.4M	$20.5M	$22.8M
Operating lease right of use assets	$39.0M	$41.3M	$49.5M	$54.6M
Goodwill	$1.1B	$1.1B	$1.1B	$1.2B
Intangible assets, net	$92.6M	$89.6M	$94.0M	$95.9M
Receivables under insured programs	$28.8M	$22.4M	$21.3M	$22.9M
Other long-term assets	$16.9M	$45.5M	$58.2M	$86.2M
Total assets	$2.0B	$1.7B	$1.6B	$1.7B
Accounts payable and other accrued liabilities	$32.0M	$36.4M	$30.1M	$44.6M
Accrued payroll and employee benefits	$108.1M	$87.7M	$67.2M	$43.8M
Current portion of insurance reserves - insured programs	$2.8M	$12.5M	$9.3M	$4.4M
Current portion of insurance reserves	$17.2M	$18.4M	$20.9M	$27.5M
Securitization obligations	$165.0M	$168.8M	$155.0M	$140.0M
Current portion of long-term obligations	$13.3M	$9.2M	$9.2M	$9.2M
Current portion of operating lease liabilities	$16.0M	$15.5M	$14.9M	$13.1M
Other current liabilities	$70.2M	$53.7M	$48.2M	$43.8M
Total current liabilities	$424.5M	$402.2M	$354.8M	$326.5M
Long-term obligations, less current portion	$1.3B	$1.3B	$1.3B	$1.3B
Long-term insurance reserves - insured programs	$28.8M	$22.4M	$21.3M	$22.9M
Long-term insurance reserves	$49.1M	$44.5M	$40.3M	$35.5M
Operating lease liabilities, less current portion	$27.4M	$31.7M	$39.8M	$45.8M
Other long-term liabilities	$800.0K	$7.1M	$3.0M	$359.0K
Total liabilities	$1.8B	$1.8B	$1.7B	$1.7B
Deferred restricted stock units	$730.0K	$1.5M	$2.1M	$2.1M
Common stock, $0.01 par value, 1,000,000,000 shares authorized; 210,996,359 and 193,225,177 issued and outstanding, respectively	2.1M	1.9M	1.9M	1.9M
Additional paid-in capital	$1.3B	$1.3B	$1.2B	$1.2B
Accumulated deficit	($1.2B)	($1.4B)	($1.4B)	($1.2B)
Total stockholders' equity (deficit)	$194.5M	($123.6M)	($129.6M)	($6.3M)
Total liabilities, deferred restricted stock units, and stockholders' equity (deficit)	$2.0B	$1.7B	$1.6B	$1.7B

Aveanna Healthcare Holdings balance sheet, quarters

Line item	Jul 4, 2026	Apr 4, 2026	Sep 27, 2025	Jun 28, 2025
Cash and cash equivalents	$97.2M	$189.3M	$145.9M	$100.7M
Patient accounts receivable	$337.2M	$332.7M	$312.8M	$316.3M
Receivables under insured programs	$3.8M	$2.9M	$4.7M	$4.4M
Prepaid expenses	$22.2M	$23.8M	$14.5M	$18.3M
Other current assets	$17.7M	$26.6M	$24.8M	$10.2M
Total current assets	$478.1M	$575.3M	$502.6M	$449.9M
Property and equipment, net	$18.4M	$17.9M	$17.4M	$17.9M
Operating lease right of use assets	$38.4M	$36.0M	$37.9M	$38.6M
Goodwill	$1.3B	$1.1B	$1.1B	$1.1B
Intangible assets, net	$99.8M	$91.9M	$93.9M	$94.4M
Receivables under insured programs	$38.3M	$30.4M	$22.1M	$21.1M
Deferred income taxes	$136.8M	$137.1M	$6.5M	$6.5M
Other long-term assets	$20.5M	$12.3M	$20.3M	$30.3M
Total assets	$2.1B	$2.0B	$1.8B	$1.8B
Accounts payable and other accrued liabilities	$32.4M	$34.4M	$27.1M	$46.6M
Accrued payroll and employee benefits	$98.2M	$77.4M	$109.5M	$92.1M
Current portion of insurance reserves - insured programs	$3.8M	$2.9M	$4.7M	$4.4M
Current portion of insurance reserves	$19.9M	$18.2M	$17.9M	$16.7M
Securitization obligations	$165.0M	$165.0M	$165.0M	$168.8M
Current portion of long-term obligations	$13.3M	$13.3M	$13.3M	$9.2M
Current portion of operating lease liabilities	$16.4M	$15.5M	$15.9M	$16.1M
Other current liabilities	$62.3M	$63.9M	$56.4M	$60.4M
Total current liabilities	$411.3M	$390.4M	$409.7M	$414.2M
Long-term obligations, less current portion	$1.3B	$1.3B	$1.3B	$1.3B
Long-term insurance reserves - insured programs	$38.3M	$30.4M	$22.1M	$21.1M
Long-term insurance reserves	$58.1M	$51.8M	$45.5M	$42.4M
Operating lease liabilities, less current portion	$26.0M	$24.6M	$26.6M	$27.7M
Other long-term liabilities	$0	$0	$800.0K	$800.0K
Total liabilities	$1.8B	$1.8B	$1.8B	$1.8B
Deferred restricted stock units	$730.0K	$730.0K	$730.0K	$730.0K
Preferred stock, $0.01 par value as of July 4, 2026 and January 3, 2026 5,000,000 shares authorized; none issued or outstanding	0	0	—	—
Common stock, $0.01 par value, 1,000,000,000 shares authorized; 217,510,046 and 210,996,359 issued and outstanding, respectively	2.2M	2.2M	2.1M	2.1M
Additional paid-in capital	$1.4B	$1.4B	$1.3B	$1.3B
Accumulated deficit	($1.1B)	($1.1B)	($1.3B)	($1.3B)
Total stockholders' equity	$287.3M	$240.1M	$9.2M	($12.0M)
Total liabilities, deferred restricted stock units, and stockholders' equity	$2.1B	$2.0B	$1.8B	$1.8B

Cash flow statement

Aveanna Healthcare Holdings cash flow statement, fiscal years

Line item	Jan 3, 2026 · FY	Dec 28, 2024 · FY	Dec 30, 2023 · FY	Dec 31, 2022 · FY
Net income (loss)	$225.0M	($10.9M)	($134.5M)	($662.0M)
Depreciation and amortization	$10.5M	$10.8M	$13.8M	$21.3M
Amortization of deferred debt issuance costs	$5.9M	$5.5M	$5.2M	$7.8M
Reduction in carrying amount of operating lease right of use assets	$17.7M	$20.4M	$16.3M	$17.5M
Non-cash share-based compensation	$25.1M	$17.5M	$13.2M	$15.9M
Loss on disposal or impairment of licenses, property and equipment, and software	$1.9M	$3.2M	$2.8M	$3.5M
Fair value adjustments on interest rate derivatives	$29.7M	$15.2M	$28.3M	($85.4M)
Loss on debt extinguishment	$5.9M	—	—	—
Deferred income taxes	($143.0M)	$1.0M	$1.0M	($115.0K)
Patient accounts receivable	($30.2M)	($28.6M)	($15.3M)	($3.2M)
Prepaid expenses	$6.5M	$6.0M	$7.0M	$9.4M
Other current and long-term assets	($26.8M)	($20.6M)	($16.7M)	($1.7M)
Accounts payable and other accrued liabilities	($6.2M)	$6.4M	($13.9M)	($3.9M)
Accrued payroll and employee benefits	$15.7M	$20.5M	$23.3M	($10.7M)
Insurance reserves	$2.2M	$1.7M	($1.8M)	$18.2M
Operating lease liabilities	($19.3M)	($19.6M)	($15.4M)	($19.6M)
Other current and long-term liabilities	$5.5M	$4.2M	$9.4M	($5.0M)
Net cash provided by operating activities	$125.9M	$32.6M	$22.7M	($48.4M)
Acquisitions of businesses, net of cash acquired	($14.9M)	—	—	($2.0M)
Purchases of property and equipment, and software	($7.4M)	($6.3M)	($6.1M)	($12.0M)
Net cash used in investing activities	($22.3M)	($6.3M)	($8.8M)	($25.3M)
Payments for shares withheld to cover employee taxes on vesting of restricted stock	-6.3M	—	—	—
Proceeds from exercise of options	$212.0K	—	—	—
Proceeds from employee stock purchase plan	$6.3M	$3.1M	$945.0K	$4.0M
Proceeds from securitization obligation	$0	$25.0M	$50.0M	$40.0M
Repayment of securitization obligation	($3.8M)	($11.3M)	($35.0M)	($20.0M)
Proceeds from issuance of term loans, net of debt issuance costs	$1.3B	—	—	$59.7M
Principal payments on term loans	($1.3B)	($9.2M)	($9.2M)	($8.9M)
Principal payments on notes payable	($8.9M)	($6.6M)	($9.8M)	($9.9M)
Principal payments on financing lease obligations	$0	($267.0K)	($665.0K)	($799.0K)
Payment of debt issuance costs	($3.6M)	($2.2M)	($1.0M)	($218.0K)
Settlements with interest rate swap counterparties	$12.6M	$15.5M	($15.6M)	—
Net cash provided by financing activities	$5.4M	$14.0M	$10.8M	$62.4M
Net change in cash and cash equivalents	$109.0M	$40.3M	$24.7M	($11.3M)
Cash and cash equivalents at beginning of period	$84.3M	$43.9M	$19.2M	$30.5M
Cash and cash equivalents at end of period	$193.3M	$84.3M	$43.9M	$19.2M
Cash paid for interest	$143.1M	$152.5M	$137.9M	$102.5M
U.S. Federal	$24.5M	—	—	—
California	$2.9M	—	—	—
Other State and Local	$3.4M	—	—	—
Foreign	$0	—	—	—
Total Cash paid for income taxes, net of refunds received	$30.8M	$5.7M	$1.1M	$1.6M
Financed insurance premiums	$9.2M	—	—	—

Aveanna Healthcare Holdings cash flow statement, quarters

Line item	Jul 4, 2026 · YTD	Apr 4, 2026 · Q1	Sep 27, 2025 · YTD	Jun 28, 2025 · YTD
Net income	$81.9M	$41.7M	$46.3M	$32.2M
Depreciation and amortization	$5.9M	$3.0M	$7.8M	$5.2M
Amortization of deferred debt issuance costs	$1.9M	$965.0K	$4.8M	$3.4M
Reduction in carrying amount of operating lease right of use assets	$9.3M	$4.6M	$13.2M	$8.7M
Non-cash share-based compensation	$8.3M	$4.1M	$21.1M	$16.2M
Loss on disposal or impairment of licenses, property and equipment, and software	$120.0K	($24.0K)	$721.0K	$319.0K
Fair value adjustments on interest rate derivatives	$1.2M	$647.0K	$23.7M	$17.6M
Deferred income taxes	$0	$0	$607.0K	$607.0K
Patient accounts receivable	($12.8M)	($19.3M)	($25.0M)	($31.0M)
Prepaid expenses	$1.0M	($2.9M)	$5.6M	$1.5M
Other current and long-term assets	$7.3M	$4.7M	($15.3M)	($3.8M)
Accounts payable and other accrued liabilities	$94.0K	$2.5M	($11.2M)	$8.2M
Accrued payroll and employee benefits	($12.2M)	($30.7M)	$17.5M	$111.0K
Insurance reserves	$9.6M	$3.7M	($644.0K)	($4.9M)
Operating lease liabilities	($9.7M)	($4.9M)	($14.5M)	($9.5M)
Other current and long-term liabilities	($6.8M)	($3.9M)	($4.4M)	($1.7M)
Net cash provided by operating activities	$85.3M	$4.3M	$76.1M	$42.9M
Acquisitions of businesses, net of cash acquired	($169.4M)	—	($14.9M)	($14.9M)
Payment for interest rate cap premium	($4.6M)	—	—	—
Purchases of property and equipment, and software	($5.8M)	($4.6M)	($5.5M)	($3.5M)
Net cash used in investing activities	($179.9M)	($4.6M)	($20.3M)	($18.3M)
Payment for shares withheld to cover employee taxes on vesting of restricted stock	-478.0K	-478.0K	-6.3M	-6.3M
Proceeds from employee stock purchase plan	$2.5M	$0	$3.9M	$1.8M
Proceeds from exercise of options	$605.0K	$269.0K	—	—
Principal payments on term loans	($3.3M)	($3.3M)	($1.3B)	($4.6M)
Principal payments on notes payable	($5.0M)	($2.4M)	($5.9M)	($4.1M)
Payment of debt issuance costs	$0	—	($3.6M)	($1.1M)
Settlements with interest rate swap counterparties	$4.3M	$2.1M	$9.2M	$6.1M
Net cash used in financing activities	($1.4M)	($3.8M)	$5.8M	($8.2M)
Net change in cash and cash equivalents	($96.1M)	($4.0M)	$61.6M	$16.4M
Cash and cash equivalents at beginning of period	$193.3M	$193.3M	$84.3M	$84.3M
Cash and cash equivalents at end of period	$97.2M	$189.3M	$145.9M	$100.7M
Cash paid for interest	$54.9M	$27.9M	$113.2M	$69.2M
Cash paid for income taxes, net of refunds received	$13.0M	($11.0K)	$24.3M	$15.7M
Financed insurance premiums	$1.7M	—	—	—

Aveanna Healthcare Holdings score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.